The digestive system is an incredibly important part of the body, responsible for breaking down food, absorbing nutrients, and eliminating waste. Unfortunately, digestive health issues are incredibly common, with many people suffering from conditions such as irritable bowel syndrome (IBS), Crohn’s disease, and ulcerative colitis. A medication called Trulance (plecanatide) has been approved by the FDA to help improve digestive health, and this article will discuss how doctors can unlock the benefits of Trulance for their patients.
Trulance is a medication that is used to treat adults with chronic idiopathic constipation (CIC) or irritable bowel syndrome with constipation (IBS-C). It is a guanylate cyclase-C agonist, which means that it helps to stimulate the body’s natural production of a hormone called guanylate cyclase-C, which helps to regulate the digestive system. Trulance works by increasing the amount of fluid in the intestines, which helps to soften stools and make them easier to pass.
Trulance works by stimulating the guanylate cyclase-C receptors in the digestive system. These receptors are responsible for regulating electrolyte and water balance in the intestines. When Trulance stimulates these receptors, it causes the intestines to secrete more fluids, which helps to soften stools and make them easier to pass.
The primary benefit of Trulance is that it can help to improve digestive health by relieving symptoms of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Trulance can help to reduce abdominal pain, bloating, and constipation. It can also help to reduce the frequency of bowel movements, and to improve the consistency of stools.
Trulance is primarily used to treat adults with chronic idiopathic constipation (CIC) or irritable bowel syndrome with constipation (IBS-C). It is important to note that Trulance is not recommended for children under the age of 18, as it has not been studied in this age group. It is also not recommended for pregnant or breastfeeding women, as it has not been studied in this population.
Like all medications, Trulance can cause side effects. The most common side effects of Trulance are abdominal pain, flatulence, diarrhea, nausea, and headache. It is important to note that these side effects are generally mild and do not last long. However, if any of these side effects become severe or persist, it is important to contact a doctor.
Trulance is typically taken once daily, with or without food. The recommended dose for adults is 3 mg once daily. It is important to note that Trulance should not be taken more than once daily, as this could increase the risk of side effects.
Trulance is a medication that is used to treat adults with chronic idiopathic constipation (CIC) or irritable bowel syndrome with constipation (IBS-C). It works by stimulating the guanylate cyclase-C receptors in the digestive system, which helps to increase the amount of fluid in the intestines and soften stools. The primary benefit of Trulance is that it can help to improve digestive health by relieving symptoms of CIC and IBS-C. It is important to note that Trulance is not recommended for children under the age of 18, pregnant or breastfeeding women, or those who take more than the recommended dose. Doctors can unlock the benefits of Trulance for their patients by discussing the potential benefits and side effects of the medication, and providing the correct dosing instructions.
1.
Pollution exposure may affect lung cancer in women who have never smoked
2.
Targeted Combination Shows Promise in Metastatic Kidney Cancer
3.
Approved BTK Inhibitor Without Covalent Bond for CLL.
4.
Xerostomia in Head and Neck Cancer Patients Can Be Predicted by Mid-Treatment PET/CT Scans.
5.
No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances
1.
The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment
2.
Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment
3.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
4.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
5.
AI-Powered Case Studies in Oncology: Elevating Clinical Influence Through Real-World Data
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation